Literature DB >> 8230464

The hemagglutinins of duck and human H1 influenza viruses differ in sequence conservation and in glycosylation.

M D Inkster1, V S Hinshaw, I T Schulze.   

Abstract

We determined the deduced amino acid sequences of two H1 duck influenza A virus hemagglutinins (HAs) and found that the consensus sequence of the HA, determined directly from virus recovered from the intestinal tract, remains unchanged through many generations of growth in MDCK cells and chicken embryos. These two duck viruses differ from each other by 5 amino acids and from A/Dk/Alberta/35/1976 (F. J. Austin, Y. Kawaoka, and R. G. Webster, J. Gen. Virol. 71:2471-2474, 1990) by 9 and 12 amino acids, most of which are in the HA1 subunit. They are antigenically similar to each other but different from the Alberta virus. We compared these H1 duck HAs with the HAs of human isolates to identify structural properties of this viral glycoprotein that are associated with host range. By comparison to the human H1 HAs, the duck virus HA sequences are highly conserved as judged by the small fraction of nucleotide differences between strains which result in amino acid substitutions. However, the most striking difference between these duck and human HAs is in the number and distribution of glycosylation sites. Whereas duck and swine viruses have four and five conserved glycosylation sites per HA1 subunit, none of which are on the tip of the HA, all human viruses have at least four additional sites, two or more of which are on the tip of the HA. These findings stress the role of glycosylation in the control of host range and suggest that oligosaccharides on the tip of the HA are important to the survival of H1 viruses in humans but not in ducks or swine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230464      PMCID: PMC238209     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Characterization of host cell binding variants of influenza virus by monoclonal antibodies.

Authors:  B Nohinek; W Gerhard; I T Schulze
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

2.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

3.  Genetic reassortment of influenza A viruses in the intestinal tract of ducks.

Authors:  V S Hinshaw; W J Bean; R G Webster; G Sriram
Journal:  Virology       Date:  1980-04-30       Impact factor: 3.616

4.  Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype.

Authors:  G Winter; S Fields; G G Brownlee
Journal:  Nature       Date:  1981-07-02       Impact factor: 49.962

5.  Oligosaccharide composition of an influenza virus hemagglutinin with host-determined binding properties.

Authors:  C M Deom; I T Schulze
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

6.  Failure to detect hemagglutination-inhibiting antibodies with intact avian influenza virions.

Authors:  B L Lu; R G Webster; V S Hinshaw
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man.

Authors:  M Pensaert; K Ottis; J Vandeputte; M M Kaplan; P A Bachmann
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

8.  A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody.

Authors:  J J Skehel; D J Stevens; R S Daniels; A R Douglas; M Knossow; I A Wilson; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

9.  Novel influenza A viruses isolated from Canadian feral ducks: including strains antigenically related to swine influenza (Hsw1N1) viruses.

Authors:  V S Hinshaw; R G Webster; B Turner
Journal:  J Gen Virol       Date:  1978-10       Impact factor: 3.891

10.  Biological properties of a hemagglutinin mutant of influenza virus selected by host cells.

Authors:  D M Crecelius; C M Deom; I T Schulze
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

View more
  13 in total

1.  Genetic characterization of an H1N2 influenza virus isolated from a pig in Indiana.

Authors:  A I Karasin; C W Olsen; G A Anderson
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes.

Authors:  H H Nguyen; P N Boyaka; Z Moldoveanu; M J Novak; H Kiyono; J R McGhee; J Mestecky
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.

Authors:  T Ito; Y Suzuki; A Takada; A Kawamoto; K Otsuki; H Masuda; M Yamada; T Suzuki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors.

Authors:  Vasiliy P Mishin; Dmitri Novikov; Frederick G Hayden; Larisa V Gubareva
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Mucin-mimetic glycan arrays integrating machine learning for analyzing receptor pattern recognition by influenza A viruses.

Authors:  Taryn M Lucas; Chitrak Gupta; Meghan O Altman; Emi Sanchez; Matthew R Naticchia; Pascal Gagneux; Abhishek Singharoy; Kamil Godula
Journal:  Chem       Date:  2021-10-22       Impact factor: 22.804

6.  A combination in-ovo vaccine for avian influenza virus and Newcastle disease virus.

Authors:  John Steel; Svetlana V Burmakina; Colleen Thomas; Erica Spackman; Adolfo García-Sastre; David E Swayne; Peter Palese
Journal:  Vaccine       Date:  2007-12-03       Impact factor: 3.641

7.  Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Christopher F Basler
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-12       Impact factor: 11.205

8.  Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells.

Authors:  Anatoly N Mikerov; Mitch White; Kevan Hartshorn; Guirong Wang; Joanna Floros
Journal:  Med Microbiol Immunol       Date:  2007-05-23       Impact factor: 3.402

9.  Evolution of H3N2 influenza virus in a guinea pig model.

Authors:  Jinxue Long; Ruth V Bushnell; John K Tobin; Keyao Pan; Michael W Deem; Peter L Nara; Gregory J Tobin
Journal:  PLoS One       Date:  2011-07-22       Impact factor: 3.240

10.  The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties.

Authors:  M Matrosovich; N Zhou; Y Kawaoka; R Webster
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.